Sernova Biotherapeutics Inc
Loading stock data...
Stock Performance
Price History
-
Drag to select time range
-
Market Data
Market Cap
47.1M
P/E Ratio
-
52-Week High
-
52-Week Low
-
Avg Volume
-
Beta
-
Forward P/E
-
Dividend Yield
-
EV/Revenue
-
Price/Book
-
Business Overview
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.
Healthcare
Biotechnology
TSX
Key Financial Metrics
-
Revenue
-15.7M
Net Income
-
EPS (Diluted)
-10.9M
Free Cash Flow
Profitability
Gross Margin
-
Operating Margin
-
Net Profit Margin
-
EBITDA
-14.6M
Returns & Efficiency
Return on Assets (ROA)
-2060.0%
Return on Equity (ROE)
-
Dividend Yield
-
Payout Ratio
-
Financial Health
Total Assets
764,234
Total Debt
4.8M
Debt to Equity
-
Current Ratio
0.02
Company Info
| Industry | Biotechnology |
| HQ | Mississauga, Canada |
| Employees | 8 |
| Fiscal Year End | 1761868800 |
| Currency | CAD |
| Website | www.sernova.com |
Peers
Bausch + Lomb Corporation
BLCO.TO
7.9B
P/E: --
Bausch Health Companies Inc.
BHC.TO
2.5B
P/E: 12.0
Extendicare Inc.
EXE.TO
2.5B
P/E: 23.7
Sienna Senior Living Inc.
SIA.TO
2.2B
P/E: 53.2
Cronos Group Inc.
CRON.TO
1.4B
P/E: 24.1
Tilray Brands, Inc.
TLRY.TO
1.2B
P/E: --
WELL Health Technologies Corp.
WELL.TO
1.1B
P/E: --
Knight Therapeutics Inc.
GUD.TO
631.8M
P/E: --
Insider Activity
Sentiment
Bullish
Shares Bought
527,500
Shares Sold
0
Total Transactions
8
SEDAR+ Filings
View All Filings6
Annual Reports
26
Quarterly Reports
29
MD&A
136
News Releases
1
Material Changes
1
Prospectuses
10
Governance
57
Certifications
43
Other
●
2022-05-27
●
2018-08-14
Interactive Charts
Company Profile
General Information
| Company Name | Sernova Biotherapeutics Inc |
| Ticker | SVA.TO |
| Exchange | TSX |
| Sector | Healthcare |
| Industry | Biotechnology |
| Headquarters | Mississauga, Canada |
| Employees | 8 |
| Fiscal Year End | 1761868800 |
| Currency | CAD |
| Website | www.sernova.com |
Financial Summary
| Market Cap | 47.1M |
| Revenue | N/A |
| Net Income | -15.7M |
| P/E Ratio | N/A |
| EPS (Diluted) | N/A |
| Net Margin | N/A |
| ROE | N/A |
| Dividend Yield | N/A |
Business Description
Sernova Biotherapeutics Inc operates as a clinical-stage biotechnology company in Canada. The company develops regenerative medicine therapeutics comprising proprietary Cell Pouch, a bio-hybrid organ system to replicate natural body functions. Its Cell Pouch creates vascularized organs for the longevity and functionality of therapeutic cells and ensures containment for retrievability. Sernova Biotherapeutics Inc was formerly known as Sernova Corp. and changed its name to Sernova Biotherapeutics Inc in February 2025. Sernova Biotherapeutics Inc is based in Mississauga, Canada.